Search

everythinglearnresearchcommunity

for

Search:↓

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Finasteride helps reduce heart enlargement in heart failure patients.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The levonorgestrel intrauterine device for heavy periods may cause acne, hair loss, and excess hair growth.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Skin symptoms can indicate endocrine disorders and have various treatments.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.